Thuthalathi Nei for Kudal Kirumi

Phase II Clinical Study On Kudal Kirumi (NAAGA POOCHI NOI) ASCARIASIS With the Evaluation Of Siddha Trial Drug THUTHALATHI NEI In Children - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109136

Enrollment

Registered

2026-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B779- Ascariasis, unspecified

Interventions

Intervention1: THUTHALATHI NEI(INTERNAL): Trial drug is given to be 2-4 ml twice a day orally with honey for 5 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Loss of appetite Pain around umbilicus Presence of perianal itching History of passing worms in the stools Teeth grinding during sleep (bruxism)

Exclusion criteria

Exclusion criteria: Enteric fever Amoebiasis Severe anemia (Hb less than 7 g/dl)

Design outcomes

Primary

Measure	Time frame
The outcome will be assessed by absence of ova, cyst in motion investigations & symptoms reduced completely, increased Hb level, decreased ESR and absolute eosinophil count.Timepoint: 5 Days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr C Shanmuga priya

Government Siddha Medical College, Arumbakkam,Chennai.

cspriya1974@gmail.com9445661808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026